Ryohei Ogihara

Dr. Ryohei Ogihara

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TTTomoaki TAKATA
Tomoaki TAKATA
SHShintaro Hamada
Shintaro Hamada
YMYukari Mae
Yukari Mae
TITakuji Iyama
Takuji Iyama
RORyohei Ogihara
Ryohei Ogihara
Hajime IsomotoHajime Isomoto
Hajime Isomoto
Uromodulin, a urinary protein synthesized and secreted from the thick ascending limb (TAL) of the loop of Henle, is associated with hypertension through the activation of sodium reabsorption in the TAL. Uromodulin is a potential target for hypertension treatment via natriuresis. However, its biological function in epithelial cells of the distal nephron segment, particularly the collecting duct, remains unknown. Herein, we examined the regulation of uromodulin production during water deprivation in vivo as well as the effect of uromodulin on the activity of the water channel aquaporin−2 (AQP2) in vitro and in vivo using transgenic mice. Water deprivation upregulated uromodulin production; immunofluorescence experiments revealed uromodulin adhesion on the apical surface of the collecting duct. Furthermore, the activation of AQP2 was attenuated in mice lacking uromodulin. Uromodulin enhanced the phosphorylation and apical trafficking of AQP2 in mouse collecting duct cells treated with the vasopressin analog dDAVP. The uromodulin-induced apical trafficking of AQP2 was attenuated via endocytosis inhibitor treatment, suggesting that uromodulin activates AQP2 through the suppression of endocytosis. This study provides novel insights into the cross−talk between TAL and the collecting duct, and indicates that the modulation of uromodulin is a promising approach for diuresis and hypertension treatment.

1 December 2023 in Gastroenterology Research
Verified
Journal Article
Open access
PDF file
RORyohei Ogihara
Ryohei Ogihara
HKHiroki Kurumi
Hiroki Kurumi
TKTsutomu Kanda
Tsutomu Kanda
KYKazuo Yashima
Kazuo Yashima
HIHajime Isomoto
Hajime Isomoto
NYNaoyuki Yamaguchi
Naoyuki Yamaguchi
Serum Activin A Is a Novel Biomarker of Endoscopic Activity in Ulcerative Colitis

29 January 2026 in Cancers
Verified
Journal Article
Open access
PDF file
KKKoichiro Kawaguchi
Koichiro Kawaguchi
AYAtsushi Yanagitani
Atsushi Yanagitani
NNNaoya Noguchi
Naoya Noguchi
RORyohei Ogihara
Ryohei Ogihara
KYKazuo Yashima
Kazuo Yashima
Hajime IsomotoHajime Isomoto
Hajime Isomoto
Background: Endoscopic resection has become a standard curative treatment for superficial esophageal cancer. However, limited data are available regarding long-term outcomes and causes of death after curative endoscopic treatment, particularly deaths unrelated to the primary esophageal cancer. This study aimed to clarify post-treatment prognosis and to identify factors associated with mortality in patients with superficial esophageal cancer who underwent curative endoscopic resection. Methods: We conducted a multicenter cohort study in Japan to evaluate survival outcomes, causes of death, and prognostic factors in patients with superficial esophageal cancer who achieved curative resection by endoscopic treatment. Patients were stratified according to endoscopic treatment indication categories (absolute, relative, and beyond indication). Five-year overall survival and disease-specific survival were analyzed, along with risk factors for all-cause and cause-specific mortality. Results: No disease-specific deaths were observed in patients with absolute or relative indication lesions, whereas the disease-specific 5-year survival rate was 81% in patients with beyond-indication lesions. When overall mortality, including deaths from other diseases and other malignancies, was evaluated, the 5-year survival rates were 92% for absolute indication cases, 85% for relative indication cases, and 69% for beyond-indication cases. Multivariate analysis identified low body mass index (BMI) and advanced age as independent risk factors for mortality. Notably, low BMI was significantly associated with non-cancer-related death. Conclusions: Even among patients who achieve curative endoscopic treatment for superficial esophageal cancer, long-term survival is limited by deaths from other malignancies and non-cancer-related causes. Low BMI represents a clinically important prognostic factor, underscoring the need for comprehensive post-treatment surveillance and supportive care beyond cancer control.

30 October 2026 in Gastro Hep Advances
Verified
Journal Article
Open access
RORyohei Ogihara
Ryohei Ogihara
HKHiroki Kurumi
Hiroki Kurumi
SKShungo Kanetsuki
Shungo Kanetsuki
THTakeshi Hashimoto
Takeshi Hashimoto
YKYu Kamitani
Yu Kamitani
HIHajime Isomoto
Hajime Isomoto

10 April 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
JWJingJing Wei
JingJing Wei
HKHiroki Kurumi
Hiroki Kurumi
Hajime IsomotoHajime Isomoto
Hajime Isomoto
RORyohei Ogihara
Ryohei Ogihara
KMKayoko Matsushima
Kayoko Matsushima
KTKazuhiro Tsukamoto
Kazuhiro Tsukamoto
Objectives: To explore the possible relationship between Toll-like receptor (TLR) gene encoding and a predictive outcome for the loss of response (LOR) to IFX treatment among Japanese patients with Crohn’s disease (CD). Methods: An association analysis that involved 25 single-nucleotide polymorphisms (SNPs) across the TLR1, TLR2, TLR4, TLR6, TLR9, and TLR10 genes was performed on a cohort of 127 Japanese patients with CD. The therapeutic responses were evaluated at 10 weeks, 1 year, and 2 years using three different inheritance models. Results: The CD patients with a G/G genotype of rs5743565 in TLR1 were significantly less likely in the responders at 10 weeks compared with the non-responders (p = 0.023, OR = 0.206). The frequencies of the C/T or T/T genotypes of rs5743604 in the TLR1, G/A, or A/A genotypes of rs13105517 in TLR2, both in the minor allele dominant model, were significantly higher in the responders at 10 weeks as compared with those in the non-responders (p = 0.035, OR = 4.401; p = 0.017, OR = 5.473). The patients with an A/A genotype of rs13105517 in TLR2 in the minor allele recessive model were significantly less likely in the responders at one year of IFX treatment compared with those in the non-responders (p = 0.004, OR = 0.195). Conclusions: The polymorphisms of TLR1 and TLR2 can be useful as biomarkers for predicting initial and secondary LOR to IFX in Japanese CD patients. The IFX response in genetic testing may target molecules for new drugs to overcome the non-response and LOR to IFX.

3 August 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
SKShungo Kanetsuki
Shungo Kanetsuki
HKHiroki Kurumi
Hiroki Kurumi
TKTsutomu Kanda
Tsutomu Kanda
NHNatsuki Hayashi
Natsuki Hayashi
THTakeshi Hashimoto
Takeshi Hashimoto
Hajime IsomotoHajime Isomoto
Hajime Isomoto
Background/Objectives: Ultra-high-magnification endoscopy (Endocyto) visualizes microscopic mucosal structures and has been proposed as a tool for assessing mucosal inflammation. We previously developed an endocytoscopic classification system (EC-A to EC-D) for grading the severity of inflammation. In this study, we investigated the relationship between endocytoscopic classification and microRNA (miRNA) expression in 36 patients with ulcerative colitis (UC). Methods: This cross-sectional study was conducted in two phases at two institutions. In the first phase, microarray analysis was performed on biopsy samples from patients with UC and healthy controls enrolled at Nagasaki University Hospital. In the second phase, 36 patients with UC who underwent total colonoscopy via Endocyto at Tottori University Hospital were included, and selected miRNAs were analyzed via quantitative polymerase chain reaction. Results: Differentially expressed miRNAs were identified, and four (miR-141-5p, miR-192-5p, miR-194-5p, and miR-215-5p) were downregulated in inflammatory areas. Notably, miR-192-5p expression was markedly lower in the EC-B and EC-C+D groups than in the EC-A group. Furthermore, expression of CXC motif ligand 2 (CXCL2), a pro-inflammatory chemokine, was upregulated in inflammatory tissues and negatively correlated with miR-192-5p expression. Conclusions: These results indicate that reduced miR-192-5p expression is inversely associated with CXCL2 expression and that, among the miRNAs examined, miR-192-5p downregulation most consistently corresponded to the endocytoscopic classification. Our findings suggest that Endocyto may serve as a real-time, in vivo adjunct for a histology-like assessment of mucosal inflammation; its clinical utility requires prospective validation.